DUSP4 and breast cancer: As preliminary studies of Dusp4 loss alone in the mammary gland via MMTV-Cre crosses did not produce mammary gland hyperplasia (data not shown), we concluded that alternative oncogenic events more replicative of those observed commonly in basal-like breast cancer may cooperate differently with Dusp4 loss.